Our Network

Research Partner

Emakina  Brussels, Belgium

Histovia Germany

ABF Germany

ProATonce Greece

Selvita Krakow, Poland

Nencki Institute Poland

Biologicshub Novi Sad, Serbia

Biobide San Sebastián, Spain

Vivotecnia Research S.L. Madrid, Spain

Inhalation Sciences Sweden

Epithelix

Scanco Medical AG Bruettisellen, Switzerland

Biognosys AG Schlieren, Switzerland

Eawag, Department of Environmental Toxicology Dubendorf, Switzerland

Douglas Connect Switzerland

Unilabs Ltd London, UK

Protavio Ltd UK

Parallax Development Canada

Scientist.com (The Assay Depot Inc) Solana Beach, CA USA

Metabolon Inc. Morrisville, NC USA

MatTek Ashland, MA USA

CFD Research Corporation Huntsville, AL USA

BTI/Cornell Ithaca, NY USA

Biodati Rahway, NJ USA

Long-Term Study Partner

Cross-Sectional Survey Germany, NCT03527017 Germany

Cross-Sectional Survey Italy, NCT03527004 Italy

Cross-Sectional Survey London, NCT03527030 London, UK

Japanese Cross-Sectional Study nationwide in Japan

Japanese Post-Market Cohort Study, NCT03020667 several cities in Japan

Smoke-free product production site

Future smoke-free product Production Site Dresden, Germany

Smoke-free product production site at the Papastratos Cigarette Manufacturing Company Greece

Philip Morris Manufacturing & Technology Bologna S.p.A. Crespellano, BO, Italy

Smoke-free product production site Otopeni, Romania

Philip Morris Products SA, Manufacturing Facility Neuchatel, Switzerland

Smoke-free product production site Yangsan, Korea

R&D Location

The iCube, Research&Development Facility Neuchatel, Switzerland

Philip Morris International Management SA Lausanne, Switzerland

Philip Morris International Research & Development Facility Yerevan, Armenia

Independent Analytical Laboratory

Labstat International ULC Kitchener, ON, Canada

Clinical Study

Reduced exposure clinical study 5 days, CHTP, NCT02503254 Poland

Reduced exposure clinical study 5 days, THS, NCT01959932 Poland

Reduced exposure clinical study 90 days, CHTP, NCT02641587 Poland

User acceptability clinical study, NSP, NCT03369340 Switzerland

User acceptability clinical study, THS menthol, NCT01967732 United Kingdom

User acceptability clinical study, e-cigarettes, NCT03379740 United States

User acceptability clinical study, THS menthol, NCT01967719 United States

Smoking cessation clinical study, NCT02432729 United States, United Kingdom, Poland, Germany, Japan

Exposure response clinical study 26 weeks, THS, NCT02396381 United States 

26-week extension to the Exposure response clinical study, THS, NCT02649556 United States

Reduced exposure clinical study 90 days, THS menthol, NCT01989156 United States

User acceptability clinical study, NSP, NCT02643693 United States

Real-life passive exposure clinical study, THS, NCT03550989 Tokyo, Japan

User acceptability clinical study, THS menthol, NCT01967706 Japan

User acceptability clinical study, THS, NCT01959607 Japan

User acceptability clinical study, e-cigarettes, NCT03379740 United States

Reduced exposure clinical study 90 days, THS, NCT01970995 Tokyo, Japan

Reduced exposure clinical study 5 days, THS, NCT01970982 Tokyo, Japan

User acceptability clinical study, NSP, NCT02532374 New Zealand

Investigator Initiated Study

Leaching of chemicals of environmental concern from used heated tobacco sticks to natural water and comparison with leaching from smoked conventional cigarettes Technical University of Crete

A 12-weeks open label, non-inferiority trial comparing HnB products vs ECs in terms of efficacy and adoption rates, acceptability, tolerability, and tobacco harm reduction in healthy smokers, not motivated to quit. University of Catania

Research on the Effects of Exhaled Pollutants from Tobacco Heating System (THS) on Indoor Air Quality Kaunas University of Technology

A Proof-of-concept, Open-label, Three-arm Study to Evaluate Mobile Applications and Biosensing (mHealth) Devices to Monitor Physical Activity, Respiratory Function, and Antioxidant Capacity in Smokers with and without Respiratory Symptoms/COPD Kazakhstan Academy of Preventive Medicine

Cross-sectional study of COPD and smoking Kazakhstan Academy of Preventive Medicine

A 5-year cohort observational study to evaluate frequency of exacerbations, respiratory symptoms, physical exercise intolerance and abnormal lung functions among participants who use IQOS with heatsticks compared to smokers of conventional cigarettes Kazakhstan Academy of Preventive Medicine

Technical Partner

Technical Partner Malaysia